SOX9 and chondrosarcoma: These results suggest that miR-494 could inhibit cell proliferation and invasion of chondrosarcoma cells in vivo and in vitro by directly decreasing SOX9 expression, and miR-494 is an independent prognosis predictor for chondrosarcoma patients.